.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Mallinckrodt
Johnson and Johnson
Cerilliant
Argus Health
Accenture
Citi
Covington
Chinese Patent Office
Fish and Richardson
Healthtrust

Generated: June 25, 2017

DrugPatentWatch Database Preview

Trospium chloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for trospium chloride and what is the scope of trospium chloride freedom to operate?

Trospium chloride
is the generic ingredient in three branded drugs marketed by Allergan, Apotex, Upsher-smith Labs, Heritage Pharms Inc, Paddock Llc, Glenmark Generics, Invagen Pharms, and Actavis Labs Fl Inc, and is included in ten NDAs. There are six patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Trospium chloride has thirteen patent family members in ten countries.

There are sixteen drug master file entries for trospium chloride. Nine suppliers are listed for this compound.

Summary for Generic Name: trospium chloride

Tradenames:3
Patents:6
Applicants:8
NDAs:10
Drug Master File Entries: see list16
Suppliers / Packagers: see list9
Bulk Api Vendors: see list58
Clinical Trials: see list452
Patent Applications: see list959
Therapeutic Class:Genitourinary Agents
Drug Prices:see low prices
DailyMed Link:trospium chloride at DailyMed

Pharmacology for Ingredient: trospium chloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Invagen Pharms
TROSPIUM CHLORIDE
trospium chloride
TABLET;ORAL091688-001Aug 23, 2016ABRXNoNo► Subscribe► Subscribe
Paddock Llc
TROSPIUM CHLORIDE
trospium chloride
TABLET;ORAL091573-001Nov 17, 2010ABRXNoNo► Subscribe► Subscribe
Upsher-smith Labs
TROSPIUM CHLORIDE
trospium chloride
CAPSULE, EXTENDED RELEASE;ORAL091635-001Apr 29, 2015DISCNNoNo► Subscribe► Subscribe
Actavis Labs Fl Inc
TROSPIUM CHLORIDE
trospium chloride
CAPSULE, EXTENDED RELEASE;ORAL091289-001Oct 12, 2012ABRXNoYes► Subscribe► Subscribe
Allergan
SANCTURA
trospium chloride
TABLET;ORAL021595-001May 28, 2004DISCNYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: trospium chloride

Country Document Number Estimated Expiration
Japan2012144577► Subscribe
Japan5783489► Subscribe
European Patent Office2210605► Subscribe
Denmark2210605► Subscribe
World Intellectual Property Organization (WIPO)2005046684► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Harvard Business School
Chubb
Fuji
US Army
Boehringer Ingelheim
Julphar
Accenture
Cantor Fitzgerald
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot